The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000249.4(MLH1):c.1646T>C (p.Leu549Pro)

CA006221

89816 (ClinVar)

Gene: MLH1
Condition: Lynch syndrome 1
Inheritance Mode: Autosomal dominant inheritance
UUID: 5f4e45d9-90b4-4312-9150-265a2d45c21c
Approved on: 2024-09-19
Published on: 2024-10-11

HGVS expressions

NM_000249.4:c.1646T>C
NM_000249.4(MLH1):c.1646T>C (p.Leu549Pro)
NC_000003.12:g.37040273T>C
CM000665.2:g.37040273T>C
NC_000003.11:g.37081764T>C
CM000665.1:g.37081764T>C
NC_000003.10:g.37056768T>C
NG_007109.2:g.51924T>C
ENST00000413740.2:c.1646T>C
ENST00000429117.6:c.1352T>C
ENST00000450420.6:c.1559-10213T>C
ENST00000456676.7:c.1646T>C
ENST00000492474.6:c.923T>C
ENST00000616768.6:c.1646T>C
ENST00000673673.2:c.1646T>C
ENST00000231790.8:c.1646T>C
ENST00000413212.2:c.*564T>C
ENST00000432299.6:c.*1478T>C
ENST00000441265.6:c.923T>C
ENST00000447829.6:c.*757T>C
ENST00000539477.6:c.923T>C
ENST00000616768.5:c.683T>C
ENST00000673673.1:c.1599T>C
ENST00000673715.1:c.1646T>C
ENST00000673889.1:n.1028T>C
ENST00000673897.1:c.*1438T>C
ENST00000673899.1:c.914T>C
ENST00000673947.1:c.*1786T>C
ENST00000673972.1:c.*1524T>C
ENST00000673990.1:n.1537T>C
ENST00000674019.1:c.923T>C
ENST00000674111.1:c.1646T>C
ENST00000674125.1:n.357T>C
ENST00000231790.6:c.1646T>C
ENST00000413740.1:c.269T>C
ENST00000435176.5:c.1352T>C
ENST00000450420.5:c.182-10213T>C
ENST00000455445.6:c.923T>C
ENST00000456676.6:c.1621T>C
ENST00000458205.6:c.923T>C
ENST00000536378.5:c.923T>C
ENST00000539477.5:c.923T>C
ENST00000616768.4:c.414T>C
NM_000249.3:c.1646T>C
NM_001167617.1:c.1352T>C
NM_001167618.1:c.923T>C
NM_001167619.1:c.923T>C
NM_001258271.1:c.1646T>C
NM_001258273.1:c.923T>C
NM_001258274.1:c.923T>C
NM_001167617.2:c.1352T>C
NM_001167618.2:c.923T>C
NM_001167619.2:c.923T>C
NM_001258274.2:c.923T>C
NM_001354615.1:c.923T>C
NM_001354616.1:c.923T>C
NM_001354617.1:c.923T>C
NM_001354618.1:c.923T>C
NM_001354619.1:c.923T>C
NM_001354620.1:c.1352T>C
NM_001354621.1:c.623T>C
NM_001354622.1:c.623T>C
NM_001354623.1:c.623T>C
NM_001354624.1:c.572T>C
NM_001354625.1:c.572T>C
NM_001354626.1:c.572T>C
NM_001354627.1:c.572T>C
NM_001354628.1:c.1646T>C
NM_001354629.1:c.1547T>C
NM_001354630.1:c.1646T>C
NM_001167617.3:c.1352T>C
NM_001167618.3:c.923T>C
NM_001167619.3:c.923T>C
NM_001258271.2:c.1646T>C
NM_001258273.2:c.923T>C
NM_001258274.3:c.923T>C
NM_001354615.2:c.923T>C
NM_001354616.2:c.923T>C
NM_001354617.2:c.923T>C
NM_001354618.2:c.923T>C
NM_001354619.2:c.923T>C
NM_001354620.2:c.1352T>C
NM_001354621.2:c.623T>C
NM_001354622.2:c.623T>C
NM_001354623.2:c.623T>C
NM_001354624.2:c.572T>C
NM_001354625.2:c.572T>C
NM_001354626.2:c.572T>C
NM_001354627.2:c.572T>C
NM_001354628.2:c.1646T>C
NM_001354629.2:c.1547T>C
NM_001354630.2:c.1646T>C
More

Likely Pathogenic

Met criteria codes 3
PM2_Supporting PP1_Strong PP3_Moderate

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for MLH1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
This NM_000249.4:c.1646T>C variant in MLH1 has been reported to segregate with disease in ≥2 families (PP1_strong). The missense variant has a prior probability for pathogenicity >0.81 (MAPP/PP2:0.82) (PP3_moderate). The variant is not reported in gnomAD v2.1.1 (non-cancer) and gnomAD v4.1 datasets (PM2_supporting). Therefore, this variant is classified as likely pathogenic. (VCEP specifications version 1)
Met criteria codes
PM2_Supporting
The variant is absent in gnomAD using the non-cancer dataset (v2.1.1) and gnomAD v4.1 dataset
PP1_Strong
This variant has been reported to segregate with disease in ≥2 families.
PP3_Moderate
Missense variant with MAPP+PolyPhen-2 prior probability for pathogenicity >0.81 (MAPP/PP2:0.82). hci-priors.hci.utah.edu/PRIORS/
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.